Demystifying Medicine Video

Diabetes and obesity are two highly prevalent chronic illnesses within today’s society, projected to cause millions of fatalities annually – far more than what’s expected from COVID-19. This video will take you through an overview of these conditions, including a discussion of the pathology and symptoms, with a major focus on brown fat and its potential as a treatment option in the foreseeable future.

[Please complete our feedback form]

  • Al-Goblan, A. S., Al-Alfi, M. A., & Khan, M. Z. (2014). Mechanism linking diabetes mellitus and obesity. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 7, 587–591.
  • Diabetes. (n.d.). Retrieved October 30, 2020, from
  • Hildebrand, S., Stümer, J., & Pfeifer, A. (2018). PVAT and its relation to brown, beige, and white adipose tissue in development and function. In Frontiers in Physiology.
  • Kumar Khemka, V., & Banerjee, A. (2017). Metabolic risk factors in obesity and diabetes mellitus: Implications in the pathogenesis and therapy. Integrative Obesity and Diabetes, 3(3).
  • Ramachandran, A. (2014). Know the signs and symptoms of diabetes. The Indian Journal of Medical Research, 140(5), 579–581.
  • Sacks, H., & Symonds, M. E. (2013). Anatomical Locations of Human Brown Adipose Tissue. Diabetes, 62(6), 1783–1790.
  • Wang, C. H., Lundh, M., Fu, A., Kriszt, R., Huang, T. L., Lynes, M. D., Leiria, L. O., Shamsi, F., Darcy, J., Greenwood, B. P., Narain, N. R., Tolstikov, V., Smith, K. L., Emanuelli, B., Chang, Y. T., Hagen, S., Danial, N. N., Kiebish, M. A., & Tseng, Y. H. (2020). CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice. Science Translational Medicine.